Top Markets
Coin of the day
Kadimastem Ltd Kadimastem Ltd

Kadimastem Ltd

KDST
Rank in Stocks #41017
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Share Price
$12.16
Last synced: 2025-10-30
Market Cap
$50.98K
Change (1 day)
-0.10%
Change (1 year)
56.95%
Country
IL
Trade Kadimastem Ltd (KDST)

Category

Dividend yield history for Kadimastem Ltd (KDST)
Kadimastem Ltd (stock symbol: KDST) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Kadimastem Ltd (KDST) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors